Anti-HCV RNA aptamers targeting the genomic cis-acting replication element

Pharmaceuticals

Volumn 5, Issue 1, 2011, Pages 49-60

  Marton, Soledad ^a   Berzal Herranz, Beatriz ^a   Garmendia, Eva ^a   Cueto, Francisco J ^a   Berzal Herranz, Alfredo ^a  

^a INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

Author keywords

Anti HCV aptamers; Aptamer selection; Aptamer therapeutics; RNA aptamers; SELEX

Indexed keywords

APTAMER; CIS ACTING ELEMENT; NONSTRUCTURAL PROTEIN 5B; RNA DIRECTED RNA POLYMERASE; VIRUS RNA;

3' UNTRANSLATED REGION; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DRUG TARGETING; GENE INTERACTION; GENE SEQUENCE; GENE STRUCTURE; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; NS5B GENE; PROTEIN DOMAIN; REPLICON; VIRUS GENE; VIRUS GENOME; VIRUS INHIBITION; VIRUS REPLICATION;

EID: 84855971178     PISSN: None     EISSN: 14248247     Source Type: Journal    
DOI: 10.3390/ph5010049     Document Type: Article

References (36)

1. Choo, Q.L.; Kuo, G.; Weiner, A.J.; Overby, L.R.; Bradley, D.W.; Houghton, M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989, 244, 359-362.
2. Poynard, T.; Yuen, M.F.; Ratziu, V.; Lai, C.L. Viral hepatitis C. Lancet 2003, 362, 2095-2100.
3. Fried, M.W.; Shiffman, M.L.; Reddy, K.R.; Smith, C.; Marinos, G.; Goncales, F.L., Jr.; Haussinger, D.; Diago, M.; Carosi, G.; Dhumeaux, D.; et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N. Engl. J. Med. 2002, 347, 975-982.
4. Domingo, E.; Gómez, J. Quasispecies and its impact on viral hepatitis. Virus Res. 2007, 127, 131-150.
5. Bukh, J.; Purcell, R.H.; Miller, R.H. Sequence analysis of the 5' noncoding region of hepatitis C virus. Proc. Natl. Acad. Sci. USA 1992, 89, 4942-4946.
6. Friebe, P.; Bartenschlager, R. Genetic analysis of sequences in the 3' nontranslated region of hepatitis C virus that are important for RNA replication. J. Virol. 2002, 76, 5326-5338.
7. Friebe, P.; Lohmann, V.; Krieger, N.; Bartenschlager, R. Sequences in the 5' nontranslated region of hepatitis C virus required for RNA replication. J. Virol. 2001, 75, 12047-12057.
8. Kolykhalov, A.A.; Mihalik, K.; Feinstone, S.M.; Rice, C.M. Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3' nontranslated region are essential for virus replication in vivo. J. Virol. 2000, 74, 2046-2051.
9. Tsukiyama-Kohara, K.; Iizuka, N.; Kohara, M.; Nomoto, A. Internal ribosome entry site within hepatitis C virus RNA. J. Virol. 1992, 66, 1476-1483.
10. Wang, C.; Sarnow, P.; Siddiqui, A. Translation of human hepatitis C virus RNA in cultured cells is mediated by an internal ribosome-binding mechanism. J. Virol. 1993, 67, 3338-3344.
11. Yi, M.; Lemon, S.M. 3' nontranslated RNA signals required for replication of hepatitis C virus RNA. J. Virol. 2003, 77, 3557-3568.
12. Yi, M.; Lemon, S.M. Structure-function analysis of the 3' stem-loop of hepatitis C virus genomic RNA and its role in viral RNA replication. RNA 2003, 9, 331-345.
13. Lee, H.; Shin, H.; Wimmer, E.; Paul, A.V. cis-Acting RNA signals in the NS5B C-terminal coding sequence of the hepatitis C virus genome. J. Virol. 2004, 78, 10865-10877.
14. You, S.; Stump, D.D.; Branch, A.D.; Rice, C.M. A cis-acting replication element in the sequence encoding the NS5B RNA-dependent RNA polymerase is required for hepatitis C virus RNA replication. J. Virol. 2004, 78, 1352-1366.
15. Friebe, P.; Boudet, J.; Simorre, J.P.; Bartenschlager, R. Kissing-loop interaction in the 3' end of the hepatitis C virus genome essential for RNA replication. J. Virol. 2005, 79, 380-392.
16. You, S.; Rice, C.M. 3' RNA elements in hepatitis C virus replication: Kissing partners and long poly(U). J. Virol. 2008, 82, 184-195.
17. Zhang, J.; Yamada, O.; Sakamoto, T.; Yoshida, H.; Araki, H.; Murata, T.; Shimotohno, K. Inhibition of hepatitis C virus replication by pol III-directed overexpression of RNA decoys corresponding to stem-loop structures in the NS5B coding region. Virology 2005, 342, 276-285.
18. Diviney, S.; Tuplin, A.; Struthers, M.; Armstrong, V.; Elliott, R.M.; Simmonds, P.; Evans, D.J. A hepatitis C virus cis-acting replication element forms a long-range RNA-RNA interaction with upstream RNA sequences in NS5B. J. Virol. 2008, 82, 9008-9022.
19. Romero-López, C.; Berzal-Herranz, A. The functional RNA domain 5BSL3.2 within the NS5B coding sequence influences hepatitis C virus IRES-mediated translation. Cell. Mol. Life Sci. 2011, doi:10.1007/s00018-011-0729-z.
20. Romero-López, C.; Berzal-Herranz, A. A long-range RNA-RNA interaction between the 5' and 3' ends of the HCV genome. RNA 2009, 15, 1740-1752.
21. Marton, S.; Reyes-Darias, J.A.; Sánchez-Luque, F.J.; Romero-López, C.; Berzal-Herranz, A. In vitro and ex vivo selection procedures for identifying potentially therapeutic DNA and RNA molecules. Molecules 2010, 15, 4610-4638.
22. Puerta-Fernández, E.; Romero-López, C.; Barroso-delJesus, A.; Berzal-Herranz, A. Ribozymes: Recent advances in the development of RNA tools. FEMS Microbiol. Rev. 2003, 27, 75-97.
23. Romero-López, C.; Sánchez-Luque, F.J.; Berzal-Herranz, A. Targets and tools: Recent advances in the development of anti-HCV nucleic acids. Infect. Disord. Drug Targets 2006, 6, 121-145.
24. Toulme, J.J.; Darfeuille, F.; Kolb, G.; Chabas, S.; Staedel, C. Modulating viral gene expression by aptamers to RNA structures. Biol. Cell 2003, 95, 229-238.
25. Tuerk, C.; Gold, L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 1990, 249, 505-510.
26. Ducongè, F.; Toulme, J.J. In vitro selection identifies key determinants for loop-loop interactions: RNA aptamers selective for the TAR RNA element of HIV-1. RNA 1999, 5, 1605-1614.
27. Fukuda, K.; Toyokawa, Y.; Kikuchi, K.; Konno, K.; Ishihara, R.; Fukazawa, C.; Nishikawa, S.; Hasegawa, T. Isolation of RNA aptamers specific for the 3' X tail of HCV. Nucleic Acids Symp. Ser. (Oxf.) 2008, 2, 205-206.
28. Kikuchi, K.; Umehara, T.; Fukuda, K.; Kuno, A.; Hasegawa, T.; Nishikawa, S. A hepatitis C virus (HCV) internal ribosome entry site (IRES) domain III-IV-targeted aptamer inhibits translation by binding to an apical loop of domain IIId. Nucleic Acids Res. 2005, 33, 683-692.
29. Kolb, G.; Reigadas, S.; Castanotto, D.; Faure, A.; Ventura, M.; Rossi, J.J.; Toulme, J.J. Endogenous expression of an anti-TAR aptamer reduces HIV-1 replication. RNA Biol. 2006, 3, 150-156.
30. Romero-López, C.; Díaz-González, R.; Berzal-Herranz, A. Inhibition of hepatitis C virus internal ribosome entry site-mediated translation by an RNA targeting the conserved IIIf domain. Cell. Mol. Life Sci. 2007, 64, 2994-3006.
31. Romero-López, C.; Díaz-González, R.; Barroso-delJesus, A.; Berzal-Herranz, A. Inhibition of hepatitis C virus replication and internal ribosome entry site-dependent translation by an RNA molecule. J. Gen. Virol. 2009, 90, 1659-1669.
32. Tallet-Lopez, B.; Aldaz-Carroll, L.; Chabas, S.; Dausse, E.; Staedel, C.; Toulme, J.J. Antisense oligonucleotides targeted to the domain IIId of the hepatitis C virus IRES compete with 40S ribosomal subunit binding and prevent in vitro translation. Nucleic Acids Res. 2003, 31, 734-742.
33. Lohmann, V.; Korner, F.; Koch, J.; Herian, U.; Theilmann, L.; Bartenschlager, R. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 1999, 285, 110-113.
34. Theissen, G.; Richter, A.; Lukacs, N. Degree of biotinylation in nucleic acids estimated by a gel retardation assay. Anal. Biochem. 1989, 179, 98-105.
35. Larrea, E.; Aldabe, R.; Molano, E.; Fernandez-Rodriguez, C.M.; Ametzazurra, A.; Civeira, M.P.; Prieto, J. Altered expression and activation of signal transducers and activators of transcription (STATs) in hepatitis C virus infection: In vivo and in vitro studies. Gut 2006, 55, 1188-1196.
36. Martell, M.; Gómez, J.; Esteban, J.I.; Sauleda, S.; Quer, J.; Cabot, B.; Esteban, R.; Guardia, J. High-throughput real-time reverse transcription-PCR quantitation of hepatitis C virus RNA. J. Clin. Microbiol. 1999, 37, 327-332.